BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29935962)

  • 21. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
    Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A
    Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.
    Feng H; Larrivee CL; Demireva EY; Xie H; Leipprandt JR; Neubig RR
    PLoS One; 2019; 14(1):e0211066. PubMed ID: 30682176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.
    Law CY; Chang ST; Cho SY; Yau EK; Ng GS; Fong NC; Lam CW
    Clin Chim Acta; 2015 Dec; 451(Pt B):292-6. PubMed ID: 26485252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual Function in Children with GNAO1-Related Encephalopathy.
    Gambardella ML; Pede E; Orazi L; Leone S; Quintiliani M; Amorelli GM; Petrianni M; Galanti M; Amore F; Musto E; Perulli M; Contaldo I; Veredice C; Mercuri EM; Battaglia DI; Ricci D
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
    Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
    Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS.
    Waak M; Mohammad SS; Coman D; Sinclair K; Copeland L; Silburn P; Coyne T; McGill J; O'Regan M; Selway R; Symonds J; Grattan-Smith P; Lin JP; Dale RC; Malone S
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):221-222. PubMed ID: 28668776
    [No Abstract]   [Full Text] [Related]  

  • 27. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
    Pérez-Dueñas B; Gorman K; Marcé-Grau A; Ortigoza-Escobar JD; Macaya A; Danti FR; Barwick K; Papandreou A; Ng J; Meyer E; Mohammad SS; Smith M; Muntoni F; Munot P; Uusimaa J; Vieira P; Sheridan E; Guerrini R; Cobben J; Yilmaz S; De Grandis E; Dale RC; Pons R; Peall KJ; Leuzzi V; Kurian MA
    Mov Disord; 2022 Nov; 37(11):2197-2209. PubMed ID: 36054588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GNAO1 Haploinsufficiency Associated with a Mild Delayed-Onset Dystonia Phenotype.
    Krenn M; Sommer R; Sycha T; Zech M
    Mov Disord; 2022 Dec; 37(12):2464-2466. PubMed ID: 36273395
    [No Abstract]   [Full Text] [Related]  

  • 29. GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to Parkinsonism.
    Solis GP; Larasati YA; Thiel M; Koval A; Koy A; Katanaev VL
    Mov Disord; 2024 Mar; 39(3):601-606. PubMed ID: 38358016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity of GNAO1-Related Disorder Correlates with Changes in G-Protein Function.
    Domínguez-Carral J; Ludlam WG; Junyent Segarra M; Fornaguera Marti M; Balsells S; Muchart J; Čokolić Petrović D; Espinoza I; Ortigoza-Escobar JD; Martemyanov KA;
    Ann Neurol; 2023 Nov; 94(5):987-1004. PubMed ID: 37548038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation.
    Miyamoto S; Nakashima M; Fukumura S; Kumada S; Saitsu H
    Neurogenetics; 2022 Apr; 23(2):129-135. PubMed ID: 35147852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.
    Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL
    Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
    Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
    Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype correlation and treatment effects in young patients with
    Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonic Cerebral Palsy Phenotype Due to GNAO1 Variant Responsive to Levodopa.
    Vasconcellos LF; Soares VP; de Ricchezza LL
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():11. PubMed ID: 37034444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Encephalopathy GNAO1].
    Bobylova MY; Volkov IV; Gumennik EV; Rachmanina OA; Abramov MO; Volkova OK; Bayborina TS; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):122-130. PubMed ID: 36719128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excellent response to deep brain stimulation in a young girl with GNAO1-related progressive choreoathetosis.
    Yilmaz S; Turhan T; Ceylaner S; Gökben S; Tekgul H; Serdaroglu G
    Childs Nerv Syst; 2016 Sep; 32(9):1567-8. PubMed ID: 27278281
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric Encephalopathy: Clinical, Biochemical and Cellular Insights into the Role of Gln52 of
    Solis GP; Kozhanova TV; Koval A; Zhilina SS; Mescheryakova TI; Abramov AA; Ishmuratov EV; Bolshakova ES; Osipova KV; Ayvazyan SO; Lebon S; Kanivets IV; Pyankov DV; Troccaz S; Silachev DN; Zavadenko NN; Prityko AG; Katanaev VL
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic modeling of GNAO1 disorder delineates mechanisms of Gαo dysfunction.
    Wang D; Dao M; Muntean BS; Giles AC; Martemyanov KA; Grill B
    Hum Mol Genet; 2022 Feb; 31(4):510-522. PubMed ID: 34508586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular annotation of G protein variants in a neurological disorder.
    Knight KM; Obarow EG; Wei W; Mani S; Esteller MI; Cui M; Ma N; Martin SA; Brinson E; Hewitt N; Soden GM; Logothetis DE; Vaidehi N; Dohlman HG
    Cell Rep; 2023 Dec; 42(12):113462. PubMed ID: 37980565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.